Pet Diabetes Care Market Size & Growth Forecast 2027–2036, By Segments (Distribution Channel, Animal Type, Solution), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Pet Diabetes Care Market size was assessed at USD 2.5 billion in 2026 and is poised to grow at a 8.93% CAGR between 2027 and 2036, exceeding USD 5.88 billion by 2036. The industry revenue for 2027 is estimated at USD 2.69 billion.
Get more details on this report
Request Free Sample ReportPet Diabetes Care Market Intelligence Snapshot
Regional Market Dynamics
- North America holds 42.40% share due to high pet ownership, strong disease awareness, established veterinary care systems, and consistent use of insulin therapy and glucose monitoring solutions.
- Asia Pacific is growing at 10.17% CAGR, supported by rising pet adoption, improving veterinary access, and increasing structured diagnosis and long-term management of pet diabetes conditions.
Segment Momentum
- Veterinary hospitals and clinics lead with 43.46% share in 2026 due to their central role in diagnosis, insulin initiation, and ongoing treatment supervision requiring professional veterinary oversight.
- Cats are the fastest-growing segment as improving veterinary awareness and owner willingness to manage feline metabolic conditions increases adoption of diagnostics, monitoring, and long-term diabetes care.
Market Expansion Drivers
- Rising prevalence of diabetes and chronic illnesses in companion animals increasing treatment demand.
- Growing pet insurance adoption improving affordability of long-term diabetic care solutions.
- Expanding companion animal ownership and veterinary healthcare spending strengthening monitoring device adoption.
Leading Market Participants
- Key companies in the pet diabetes care market include Zoetis Inc. (United States), Merck Animal Health (United States), Boehringer Ingelheim International GmbH (Germany), Becton, Dickinson and Company (United States), Nova Biomedical Corporation (United States), I-SENS, Inc. (South Korea), Allison Medical, Inc. (United States), Abbott Laboratories (United States), Elanco Animal Health Incorporated (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 2.5 billion
- 2027 Estimated Market Size: USD 2.69 billion.
- Projected Market Size: USD 5.88 billion by 2036
- Growth Forecast: 8.93% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Veterinary Hospitals & Clinics (Distribution Channel) | Dogs (Animal Type) | Treatment (Solution)
- Emerging Opportunity Segment: E-commerce (Distribution Channel) | Cats (Animal Type) | Glucose Monitoring Devices (Solution)
Market Growth Drivers and Industry Trends
Rising prevalence of diabetes and chronic illnesses in companion animals increasing treatment demand
Rising prevalence of diabetes and chronic illnesses in companion animals will drive the pet diabetes care market as veterinarians and pet owners increasingly require solutions for disease diagnosis, glucose monitoring, insulin administration, and long-term condition management. Diabetes requires consistent monitoring and treatment to maintain appropriate glucose control and reduce the risk of complications, creating recurring demand for veterinary medicines, testing supplies, and monitoring technologies. Greater recognition of chronic metabolic conditions in pets is also encouraging owners to seek professional veterinary support and structured disease-management routines.
Growing pet insurance adoption improving affordability of long-term diabetic care solutions
Growing pet insurance adoption is supporting the pet diabetes care market by improving the financial accessibility of recurring diagnostic, monitoring, and treatment requirements associated with diabetes management. Long-term diabetic care can involve regular veterinary consultations, glucose testing, medications, and specialized monitoring, making affordability an important consideration for pet owners. Insurance coverage can help reduce the direct financial burden of eligible veterinary services and encourage owners to pursue recommended care rather than delaying diagnostic evaluations or ongoing disease-management procedures.
Expanding companion animal ownership and veterinary healthcare spending strengthening monitoring device adoption
Expanding companion animal ownership and rising veterinary healthcare spending will boost the pet diabetes care market by increasing the willingness of owners to invest in technologies that support routine disease monitoring. As pets become more closely integrated into households, owners are placing greater emphasis on preventive care, chronic disease management, and quality of life. Monitoring devices can provide useful information about glucose levels and treatment response, supporting veterinarians and owners in making informed adjustments to ongoing care while reducing reliance on occasional clinical measurements alone.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of diabetes and chronic illnesses in companion animals increasing treatment demand | 2.00% | Moderate | North America, Europe | High | Near Term |
| Growing pet insurance adoption improving affordability of long-term diabetic care solutions | 1.70% | Moderate | North America, Asia Pacific | High | Mid Term |
| Expanding companion animal ownership and veterinary healthcare spending strengthening monitoring device adoption | 1.40% | Low | Asia Pacific, Latin America | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America accounted for the largest share of the pet diabetes care market at 42.40% in 2026, supported by high pet ownership, advanced veterinary healthcare infrastructure, and growing awareness of chronic disease management in companion animals. Increasing willingness among pet owners to invest in long-term veterinary care is supporting demand for diabetes diagnosis, monitoring, and treatment solutions. Greater emphasis on preventive veterinary services and improved access to specialized animal healthcare further reinforces the region’s market leadership.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, supported by rising companion animal ownership, expanding veterinary service networks, and increasing awareness of pet health management. Urbanization and changing attitudes toward pets are encouraging owners to seek more comprehensive care for chronic conditions. Improvements in veterinary diagnostic capabilities and broader access to specialized treatments are also creating favorable conditions for the adoption of diabetes care solutions.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Veterinary ManagementGermany prioritizes evidence-based veterinary diabetes care supported by advanced diagnostic practices and structured treatment protocols. German veterinary providers are integrating reliable monitoring technologies and tailored insulin therapies to strengthen chronic disease management for diabetic pets.
France 🇫🇷
Preventive Veterinary FocusFrance emphasizes earlier diagnosis and structured follow-up for diabetic companion animals through established veterinary care networks. French clinics continue incorporating modern glucose monitoring technologies to improve treatment planning and long-term patient outcomes.
Italy 🇮🇹
Specialized Clinical CareItaly is expanding access to specialized veterinary endocrinology services for companion animals requiring long-term diabetes management. Veterinary professionals in Italy are increasing the use of advanced diagnostics and individualized treatment plans to improve disease control.
Japan 🇯🇵
Aging Pet SupportJapan focuses on diabetes care solutions suited to its growing aging companion animal population. Veterinary practices in Japan are adopting minimally invasive monitoring methods and personalized treatment approaches that improve routine disease management for elderly pets.
South Korea 🇰🇷
Digital Veterinary AdoptionSouth Korea is strengthening pet diabetes management through connected veterinary services and growing acceptance of digital monitoring technologies. Companion animal clinics are expanding access to diagnostic tools and owner education that support more consistent diabetes care.
United States 🇺🇸
Advanced Companion CareThe U.S. market emphasizes continuous glucose monitoring, insulin management, and digital veterinary care for companion animals. Clinics across the U.S. are expanding preventive diabetes management services while pet owners increasingly seek convenient monitoring solutions that improve long-term treatment adherence.
Segment Leadership and Growth Trends
Pet Diabetes Care Market Share (%), by Distribution Channel, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportDistribution Channel Segment Analysis: Veterinary Hospitals & Clinics (Largest Segment) vs E-commerce (Fastest-Growing Segment)
Veterinary hospitals & clinics dominated the pet diabetes care market with a 43.46% share in 2026, supported by their central role in diagnosing diabetes, establishing treatment plans, monitoring glucose levels, and managing ongoing therapy for companion animals. Diabetes care often requires professional assessment and individualized treatment adjustments, making veterinary facilities an important channel for medications, monitoring products, and related care services. Their ability to combine diagnosis, treatment, follow-up examinations, and professional guidance within one setting reinforces their importance, particularly for owners seeking structured management of chronic pet conditions.
E-commerce is expanding more rapidly as pet owners increasingly seek convenient access to diabetes care products and recurring treatment supplies. Online purchasing enables owners to compare products, reorder essential items, and access specialized pet healthcare supplies without relying exclusively on physical veterinary or retail locations. Greater digital adoption among pet owners and the convenience of home delivery further support this channel's development. As diabetes management often involves continuing access to care products, e-commerce platforms can provide a practical purchasing option that complements veterinary-led treatment.
Animal Type Segment Analysis: Dogs (Largest Segment) vs Cats (Fastest-Growing Segment)
The dogs segment held the largest share of the pet diabetes care market in 2026, reflecting the substantial demand for diabetes management solutions within canine healthcare. Dogs diagnosed with diabetes require sustained monitoring and treatment, creating recurring demand for veterinary care, medications, glucose-management products, and supportive services. Increased awareness of chronic disease management among pet owners is also encouraging earlier diagnosis and more consistent treatment. The growing emphasis on companion-animal wellness and preventive veterinary care further supports the established position of dogs within the market.
Cats represent the fastest-growing animal type segment as awareness of feline diabetes and its management continues to strengthen. Improved recognition of metabolic disorders among cat owners is encouraging greater use of veterinary diagnostics and ongoing disease-management solutions. The increasing willingness of owners to pursue comprehensive care for chronic conditions is also supporting demand for monitoring and treatment options tailored to feline needs. As veterinary practices place greater emphasis on early detection and long-term management, the cat segment is gaining momentum within the broader pet diabetes care landscape.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Distribution Channel | Veterinary Hospitals & Clinics, Retail Pharmacies, E-commerce | Veterinary Hospitals & Clinics | E-commerce |
| Animal Type | Dogs, Cats | Dogs | Cats |
| Solution | Treatment, Glucose Monitoring Devices | Treatment | Glucose Monitoring Devices |
Competitive Landscape and Market Positioning
Key companies in the pet diabetes care market:
1. Zoetis Inc. (United States)
2. Merck Animal Health (United States)
3. Boehringer Ingelheim International GmbH (Germany)
4. Becton Dickinson and Company (United States)
5. Nova Biomedical Corporation (United States)
6. I-SENS Inc. (South Korea)
7. Allison Medical Inc. (United States)
8. Abbott Laboratories (United States)
9. Elanco Animal Health Incorporated (United States)
Rising awareness regarding chronic pet health conditions is driving innovation in the pet diabetes care market. Manufacturers are introducing advanced glucose monitoring solutions, insulin delivery systems, and specialized nutritional products tailored for companion animals. Growing expenditure on veterinary healthcare and preventive treatment solutions is also encouraging continuous expansion of diabetes management offerings in the market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Zoetis Inc. (United States) | |||||||
| Merck Animal Health (United States) | |||||||
| Boehringer Ingelheim International GmbH (Germany) | |||||||
| Becton Dickinson and Company (United States) | |||||||
| Nova Biomedical Corporation (United States) | |||||||
| I-SENS Inc. (South Korea) | |||||||
| Allison Medical Inc. (United States) | |||||||
| Abbott Laboratories (United States) | |||||||
| Elanco Animal Health Incorporated (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Boehringer Ingelheim | Aug-23 | The FDA authorized SENVELGO (velagliflozin), a novel oral SGLT2 inhibitor for the management of feline diabetes. By offering a convenient once-daily liquid formulation, the drug represents a significant therapeutic innovation that reduces the frequency of insulin injections, addressing a critical compliance barrier in pet care and establishing a new standard for glucose regulation in diabetic cats. |
| Zoetis | Sep-22 | Zoetis acquired NewMetrica, a UK-based developer of health-related quality-of-life assessment tools for pets. This acquisition integrates specialized digital monitoring capabilities into Zoetis’s existing pet health portfolio, enabling more precise clinical assessment and improved outcomes for chronic condition management, including diabetes care, through advanced data-driven veterinary diagnostics. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Pet Diabetes Care Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Diabetes Management Intensity | Routine Management, Intensive Management, Complication Management |
| Veterinary Care Provider Type | General Veterinary Practices, Specialty Veterinary Practices, Veterinary Referral Centers |
| Pet Weight Category | Small Pets, Medium-Sized Pets, Large Pets |
Pet Diabetes Care Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Pet Diabetes Management Adoption Analysis |
|
| Veterinary Care Pathway Assessment |
|
| Pet Owner Spending Behavior Analysis |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the pet diabetes care market?
How much is the pet diabetes care industry expected to grow by 2036?
How is rising diabetes prevalence in companion animals impacting demand for long-term pet diabetes care?
What role is pet insurance playing in shaping treatment adoption in the pet diabetes care market?
Why are veterinary hospitals and clinics the leading distribution channel?
Why are cats the fastest-growing animal type in pet diabetes care?
Why is North America the leading region in pet diabetes care?
What is driving Asia Pacific growth in pet diabetes care?
Which companies are driving growth in the pet diabetes care landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization